Cargando…
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
BACKGROUND: To investigate efficacy and safety of intravenous abatacept in Japanese patients with active polyarticular-course juvenile idiopathic arthritis (pJIA). METHODS: In this phase III, open-label, multicenter, single-arm study, patients with pJIA aged 4–17 years who failed ≥1 biologic or meth...
Autores principales: | Hara, Ryoki, Umebayashi, Hiroaki, Takei, Syuji, Okamoto, Nami, Iwata, Naomi, Yamasaki, Yuichi, Nakagishi, Yasuo, Kizawa, Toshitaka, Kobayashi, Ichiro, Imagawa, Tomoyuki, Kinjo, Noriko, Amano, Norihito, Takahashi, Yoko, Mori, Masaaki, Itoh, Yasuhiko, Yokota, Shumpei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492394/ https://www.ncbi.nlm.nih.gov/pubmed/31039807 http://dx.doi.org/10.1186/s12969-019-0319-4 |
Ejemplares similares
-
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
por: Imagawa, Tomoyuki, et al.
Publicado: (2012) -
Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
por: Mori, Masaaki, et al.
Publicado: (2008) -
Abatacept in the treatment of polyarticular JIA: development, clinical utility, and place in therapy
por: Goldzweig, Ofra, et al.
Publicado: (2011) -
Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011) -
Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Shimizu, Masaki, et al.
Publicado: (2020)